Cardiovascular Drugs Market
Cardiovascular Drug Market Research Report - By Drug Class (Antiarrhythmics, Antianginals, Antihypertensives, Lipid-lowering agents, Anticoagulants, Antiplatelet agents, Cardiac glycosides), By Route of Administration (Oral, Intravenous, Subcutaneous, Transdermal, Inhalation), By Indication (Coronary artery disease, Heart failure, Stroke, Atrial fibrillation, Hypertension, Hyperlipidemia, Venous thromboembolism), By Mechanism of Action (Beta-blockers, Calcium channel blockers, ACE inhibitors, Angiotensin II receptor blockers, Diuretics, Statins, Fibrates), By Dosage Form (Tablets, Capsules, Injections, Patches, Implants) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global Cardiovascular Drug Market Overview:
As per MRFR analysis, the Cardiovascular Drug Market Size was estimated at 202.34 (USD Billion) in 2022. The Cardiovascular Drug Market is expected to grow from 210.82 (USD Billion) in 2023 to 305.1 (USD..